Analysts at Jefferies initiate coverage of Health Management Associates Inc (NYSE:
HMA) with a “buy” rating. The target price for HMA is set to $13.
HMA shares fell 0.96% to close at $10.34 yesterday.
More Analyst Ratings here© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
